Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine
- 87 Downloads
Breast cancer epidemic in the early twenty-first century results in around two million new cases and half-a-million of the disease-related deaths registered annually worldwide. A particularly dramatic situation is attributed to some specific patient subgroups such as the triple-negative breast cancer (TNBC). TNBC is a particularly aggressive type of breast cancer lacking clear diagnostic approach and targeted therapies. Consequently, more than 50% of the TNBC patients die of the metastatic BC within the first 6 months of the diagnosis. In the current study we have hypothesised that multi-omic approach utilising blood samples may lead to discovery of a unique molecular signature of the TNBC subtype. The results achieved demonstrate, indeed, multi-omics as highly promising approach that could be of great clinical utility for development of predictive diagnosis, targeted prevention and treatments tailored to the person—overall advancing the management of the TNBC.
KeywordsBreast cancer Triple-negative breast cancer Menopause *Omics Predictive diagnosis Biomarker pattern
The authors thank Dr. M. Fountoulakis for his great contribution to the proteomic part of the project. Further, authors thank Ms. G. Windisch-Schuster for performing the “Western-blot” analysis.
Compliance with ethical standards
The study funding has been performed by the Breast Cancer Research Centre, University of Bonn, Bonn, Germany. KY has been awarded with corresponding fellowship by the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Belgium).
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
All the patient investigations conformed to the principles outlined in the Declaration of Helsinki and have been performed with the permission (Nr. 148/05) released by the responsible Ethic’s Committee of the Medical Faculty, Rheinische Friedrich-Wilhelms- University of Bonn. Human rights’ have been obligatory protected during the entire duration of the project according to the European standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- Agnoli C, Grioni S, Krogh V et al (2016) Plasma riboflavin and vitamin B-6, but not homocysteine, folate, or vitamin B-12, are inversely associated with breast cancer risk in the European prospective investigation into cancer and nutrition-varese cohort. J Nutr 146:1227–1234. https://doi.org/10.3945/jn.115.225433 CrossRefPubMedGoogle Scholar
- Braun M, Fountoulakis M, Papadopoulou A, Vougas K, Seidel I, Höller T, Yeghiazaryan K, Schild HH, Kuhn W, Golubnitschaja O (2009) Down-regulation of microfilamental network-associated proteins in leukocytes of breast cancer patients: potential application to predictive diagnostics. Cancer Genomic Proteomic 6:31–40Google Scholar
- Golubnitschaja O, Debald M, Yeghiazaryan K et al (2016a) Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumour Biol 37:12941–12957. https://doi.org/10.1007/s13277-016-5168-x CrossRefPubMedGoogle Scholar
- Golubnitschaja O, Yeghiazaryan K, Stricker H et al (2016b) Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer 16:357. https://doi.org/10.1186/s12885-016-2382-2 CrossRefPubMedPubMedCentralGoogle Scholar
- Golubnitschaja O, Yeghiazaryan K, Abraham J-A et al (2017) Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes. Amino Acids 49:273–281. https://doi.org/10.1007/s00726-016-2357-2 CrossRefPubMedGoogle Scholar
- Gómez-Contreras P, Ramiro-Díaz JM, Sierra A et al (2017) Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases. Clin Exp Metastasis 34:37–49. https://doi.org/10.1007/s10585-016-9827-5 CrossRefPubMedGoogle Scholar
- Jiang C, Veon W, Li H et al (2015) Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation. Cell Cycle 14:2914–2923. https://doi.org/10.1080/15384101.2015.1069929 CrossRefPubMedPubMedCentralGoogle Scholar
- Kurono S, Kaneko Y, Matsuura N et al (2016) Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry. Proteom Clin Appl 10:605–613. https://doi.org/10.1002/prca.201500016 CrossRefGoogle Scholar
- López-Cortés A, Echeverría C, Oña-Cisneros F et al (2015) Breast cancer risk associated with gene expression and genotype polymorphisms of the folate-metabolizing MTHFR gene: a case-control study in a high altitude Ecuadorian mestizo population. Tumour Biol 36:6451–6461. https://doi.org/10.1007/s13277-015-3335-0 CrossRefPubMedGoogle Scholar
- Polivka J, Kralickova M, Polivka J et al (2017) Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J 8:119–127. https://doi.org/10.1007/s13167-017-0087-5 CrossRefPubMedPubMedCentralGoogle Scholar
- Schito L, Rey S, Tafani M et al (2012) Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 109:E2707–E2716. https://doi.org/10.1073/pnas.1214019109 CrossRefPubMedPubMedCentralGoogle Scholar
- Wu X, Xu W, Zhou T et al (2016) The role of genetic polymorphisms as related to one-carbon metabolism, vitamin B6, and gene-nutrient interactions in maintaining genomic stability and cell viability in chinese breast cancer patients. Int J Mol Sci 17:E1003. https://doi.org/10.3390/ijms17071003 CrossRefPubMedGoogle Scholar
- Yeghiazaryan K, Flammer J, Golubnitschaja O (2010) Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 1:263–272. https://doi.org/10.1007/s13167-010-0032-3 CrossRefPubMedPubMedCentralGoogle Scholar